There are 1.6 million in dividuals with Type 1 Dabetes in the US.9 100% of patient population require daily insulin injection. Only 1 out of 3 currently use an insulin pump.

Pumping

32% of population utilizes insulin pumps for diabetes management

32%

Multiple Daily Injections (MDI's)

68% of the population rely on multiple daily injections for diabetes management

68%

Almost Pumpers

Almost Pumpers are 30% of the market. They would go on a pump if it were less expensive, time consuming, and technically intimidating.

$1.9bn

Market Opportunity

Three Standards

All drugs and medical devices must meet three standards.

Viable

The product must be desired by the market: feature and cost competitive, attractive to users.

Approvable

The product must be approvable by the FDA: meets all testing and regulatory requirements and specifications. Able to navigate the approval and documentation process.

Profitable

The product must be profitable to manufacture and to sell. Engineered to be low cost and easy to manufacture. Designed to be sold to and through providers, not users.

Viable
Capital
Destruction

Winner

Profitable
Non
Marketable
Approvable
No
Adoption

Discover How Modular Medical Is Addressing These Three Standards with Pivot

FreeStyle Libre vs. Dexcom Revenue

Encouraging Adoption

Abbott Libre Freestyle made continuous glucose monitoring easier and more affordable. This expanded the product category and doubled its size.

We believe the insulin pump market is ready for a similar transition.

“In short, Flash Glucose Monitoring is fundamentally trying to take something that is more “professional” (i.e., traditional CGM) and make it more accessible to the masses. In consumer-packaged goods, examples of this strategy include home espresso makers (Keurig), cleaning products (e.g., dilatable floor cleaners, spray cleaners, wipes, toilet wands), and teeth whitening (e.g., whitening strips).

In these cases, the new innovation completely changed the entire category; we look forward to seeing if Flash Glucose Monitoring does something similar in diabetes.”

-Kelly Close, 2014

Learn More About How We Are Changing Diabetes Care

If you'd like more information about our innovations, please contact us and we'll be in touch shortly.